ArticleFrontiers in psychology2026
Psychometric properties and measurement invariance of the Turkish version of the multidimensional cognitive attentional syndrome scale.
Article in Frontiers in psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cognitive attentional syndrome and metacognitive beliefs are the two elements that comprise the metacognitive therapy model. The aim of the Multidimensional Cognitive Attentional Syndrome Scale (MCASS) is to comprehensively measure this construct. Aim: To test the validity and reliability of the Turkish version of the MCASS and its use in patients and controls. Methods: A total of 229 participants (115 patients and 114 healthy controls) were included in this study. Confirmatory factor analyses, internal consistency analyses (Cronbach's Results: Confirmatory factor analyses supported the seven-factor structure of the MCASS after excluding item 7 in the patients and controls. The internal consistency was acceptable to excellent (Cronbach's Conclusion: The Turkish modified 20-item MCASS is a suitable tool for clinical and non-clinical settings. However, diagnosis-specific cognitive attentional syndrome scales are needed for comprehensive assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.